Guided Therapeutics (GTHP) Operating Margin Growth (3y) (2013 - 2025)
Guided Therapeutics (GTHP) Operating Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 244.00 |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Dec 31, 2024 | -5.27 Mn |
| Dec 31, 2023 | -36,362.00 |
| Sep 30, 2022 | -2.20 Mn |
| Jun 30, 2022 | 1.84 Mn |
| Mar 31, 2022 | -743,222.00 |
| Dec 31, 2021 | 34,405.00 |
| Sep 30, 2021 | 913,684.00 |
| Jun 30, 2021 | -2.19 Mn |
| Dec 31, 2020 | -46,882.00 |
| Sep 30, 2020 | 385,887.00 |
| Dec 31, 2019 | -126,047.00 |
| Sep 30, 2019 | -1.81 Mn |
| Dec 31, 2018 | 1.61 Mn |
| Sep 30, 2018 | 1.13 Mn |
| Jun 30, 2018 | 987,250.00 |
| Mar 31, 2018 | 52,000.00 |
| Dec 31, 2017 | 1.58 Mn |
| Sep 30, 2017 | 691,970.00 |